Alpha Teknova, Inc.

NASDAQ:TKNO

Drug Manufacturers - Specialty & Generic

Healthcare
$7.88 +4.55%

+$0.23 today

Market cap
$495.68M
Beta
0.63
P/E (TTM)
-16.2
EPS (TTM)
-$0.32
52W Low $1.91High $6.68

Volume 0.30M

Average 0.13M

TKNO Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Alpha Teknova, Inc.NASDAQ: TKNO

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 27.5% from a year ago

Cash & equivalents stood at $4.31M at the end of Q1 FY2026, up 27.5% from a year earlier and down 27.2% from the prior quarter. Over 3 fiscal years it compounded at -48.1% a year.

Context

  • Cash & equivalents amounted to 4.4% of total assets at the end of Q1 FY2026, up 1.4 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 3 fiscal years.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +27.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.31M-27.2% QoQ
Last fiscal yearDec 2025
$5.91M+59.4% YoY
Year agoMar 2025
$3.38M+27.5% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27.5%——
1 year+59.4%——
3-year CAGR-48.1%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
5.91M USD
Year-over-year change
+59.4%
4-year CAGR
-49.0%

Cash & Equivalents vs competitors

How TKNO compares with its peers on the latest reported figures

  • TKNO's Mar 2026 cash & equivalents of $4.31M is the lowest of the 8 companies compared; the peer median is $193.8M.
  • Its year-over-year change of +27.5% is the 3rd highest of 8, against a peer median of -14.4%.
  • Cash & equivalents amounts to 4.4% of total assets for TKNO, versus a peer median of 11.6%.
TKNO Competitors Peer median
Cash & Equivalents for TKNO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
RGENRepligen CorporationJun 2026$606.78M -14.4%+2.6%20.6%
TECHBio-Techne CorporationSep 2026$350.04M +141.5%+13.6%13.3%
LABStandard BioTools Inc.Mar 2026$265.77M +76.1%+13.3%41.6%
AZTAAzenta, Inc.Sep 2026$193.8M -31.3%-34.2%11.3%
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$70.09M -74.0%-30.0%11.6%
MLABMesa Laboratories, Inc.Mar 2026$26.93M -1.4%-6.5%6.3%
BLFSBioLife Solutions, Inc.Mar 2026$22.82M -65.9%+19.3%5.7%
TKNOAlpha Teknova, Inc.Mar 2026$4.31M +27.5%-48.1%4.4%
Peer median (excluding TKNO) $193.8M-14.4%+2.6%11.6%

Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents87.52M42.24M28.48M3.71M5.91M
Short-term Investments00026.69M0
Net Receivables5.85M4.28M3.95M4.31M4.62M
Inventory5.39M12.25M11.59M6.8M7.05M
Other Current Assets001.63M1.27M16.93M
Total Current Assets101.2M61.14M45.66M42.78M34.51M
Property, Plant & Equipment (Net)29.81M71.31M66.84M61.52M55.85M
Goodwill16.61M0000
Intangible Assets18.7M17.56M14.24M13.09M11.94M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets180K2.25M1.85M1.38M1.29M
Total Non-current Assets65.31M91.12M82.93M75.99M69.07M
Total Assets166.51M152.26M128.59M118.77M103.58M
Account Payables2.25M2.45M1.49M825K1.38M
Short-term Debt0004.05M1.88M
Tax Payables00000
Deferred Revenue200K198K16K30K0
Other Current Liabilities00004.28M
Total Current Liabilities7.74M10.88M8.88M11.21M7.54M
Long-term Debt11.87M21.98M13.25M9.44M13.27M
Deferred Tax Liabilities3.15M1.22M919K827K879K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities542K191K102K10K13.12M
Total Non-current Liabilities15.57M41.5M29.68M25.16M27.27M
Total Liabilities23.31M52.38M38.55M36.38M34.81M
Common Stock0001K1K
Retained Earnings(7.54M)(55.01M)(91.79M)(118.53M)(135.79M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity143.2M99.89M90.04M82.39M68.78M
Total Debt11.87M42.31M30.46M30.17M15.15M
Net Debt(75.65M)74K1.97M26.46M9.23M

Alpha Teknova, Inc.

NASDAQ:TKNO

Intrinsic Alpha fair value

Locked

Current Price

$7.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.